RelevanceRGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpeciesAnnotationsMatchType
10001298420OSTEAR5_HOsteoarthritis QTL 5 (human)1.6Joint/bone inflammationhand osteoarthritis117350513179965640Humann/aregionqtl
10001298492BP31_HBlood pressure QTL 31 (human)2.07Blood pressuresystolic1134640077123626865Humann/aregionqtl
10001331655COPD20_HChronic obstructive pulmonary disease QTL 20 (human)1.53Chronic airflow obstructionFVC1173505131105558955Humann/aregionqtl
10001357380BW64_HBody weight QTL 64 (human)2.2Body weightpercent fat after exercise training1175662287120989875Humann/aregionqtl
10001357289AASTH31_HAllergic/atopic asthma related QTL 31 (human)2Reversible airflow obstruction114097430181574509Humann/aregionqtl
10001559104SCL15_HSerum cholesterol level QTL 15 (human)2.6.06Lipid levelhyperlipidemia susceptibility111708620479965640Humann/aregionqtl
10001643317BW233_HBody weight QTL 233 (human).86Body weightbody mass index116696552192965521Humann/aregionqtl
10002289200BW356_HBody weight QTL 356 (human).0163Body fat amountpercent fat116050522886505228Humann/aregionqtl
10001643420BW275_HBody Weight QTL 275 (human)2.13.0009Body weight216696552192965521Humann/aregionqtl
10001643419BW274_HBody Weight QTL 274 (human)2.19.0008Body weight116696552192965521Humann/aregionqtl
10002289174SADIPOQ7_HSerum adiponectin level QTL 7 (human)4.2Hormone leveladiponectin level1158496495120828264Humann/aregionqtl
10001643405BMD9_HBone mineral density QTL 9 (human)2.64.0002Bone mineral density116050522886505228Humann/aregionqtl
10001643360BW339_HBody weight QTL 339 (human)2Body fat amountpercent body fat116050522886505228Humann/aregionqtl
10001643371BW329_HBody weight QTL 329 (human)2.64.0002Body fat amount116050522886505228Humann/aregionqtl
10002292918PRSTS142_HProstate tumor susceptibility QTL 142 (human)6.12.000015Prostate tumor susceptibility115489339480893394Humann/aregionqtl
10002292973PRSTS189_HProstate tumor susceptibility QTL 189 (human)6.06.0029Prostate tumor susceptibility116884483894844838Humann/aregionqtl
10002292961PRSTS192_HProstate tumor susceptibility QTL 192 (human)4.51.0045Prostate tumor susceptibility116884483894844838Humann/aregionqtl
10002292942PRSTS195_HProstate tumor susceptibility QTL 195 (human)1.28Prostate tumor susceptibility115489339480893394Humann/aregionqtl
10002293009PRSTS194_HProstate tumor susceptibility QTL 194 (human)1.57Prostate tumor susceptibility115489339480893394Humann/aregionqtl
10002292771PRSTS33_HProstate tumor susceptibility QTL 33 (human)Prostate tumor susceptibilityearly onset116050522886505228Humann/aregionqtl
10002292855MYI30_HMyocardial infarction susceptibility QTL 30 (human)Myocardial infarction susceptibilityearly-onset116696552192965521Humann/aregionqtl
10002292849MYI31_HMyocardial infarction susceptibility QTL 31 (human)Myocardial infarction susceptibilityearly-onset116696552192965521Humann/aregionqtl
10002301154PRSTS364_HProstate tumor susceptibility QTL 364 (human)Prostate tumor susceptibility116884483894844838Humann/aregionqtl
10002301147PRSTS369_HProstate tumor susceptibility QTL 369 (human)Prostate tumor susceptibility116884483894844838Humann/aregionqtl
10002300235PRSTS358_HProstate tumor susceptibility QTL 358 (human).018Prostate tumor susceptibility116050522886505228Humann/aregionqtl
10002316704GLUCO256_HGlucose level QTL 256 (human)2.98.00011Glucose level116587603591876035Humann/aregionqtl
10002316064GLUCO210_HGlucose level QTL 210 (human).027Glucose level115489339480893394Humann/aregionqtl